Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways

Open access
Weivoda, Megan M, Ruan, Ming, Hachfeld, Christine M, Pederson, Larry, Howe, Alan, Davey, Rachel A, Zajac, Jeffrey D, Kobayashi, Yasuhiro, Williams, Bart O, Westendorf, Jennifer J, Khosla, Sundeep, Oursler, Merry Jo · 2016 · Journal of Bone and Mineral Research

Abstract

Although there has been extensive characterization of the Wnt signaling pathway in the osteoblast lineage, the effects of Wnt proteins on the osteoclast lineage are less well studied. We found that osteoclast lineage cells express canonical Wnt receptors. Wnt3a reduced osteoclast formation when applied to early bone-marrow macrophage (BMM) osteoclast differentiation cultures, whereas late addition did not suppress osteoclast formation. Early Wnt3a treatment inactivated the crucial transcription factor NFATc1 in osteoclast progenitors. Wnt3a led to the accumulation of nuclear β-catenin, confirming activation of canonical Wnt signaling. Reducing low-density lipoprotein receptor-related proteins (Lrp) 5 and Lrp6 protein expression prevented Wnt3a-induced inactivation of NFATc1; however, deletion of β-catenin did not block Wnt3a inactivation of NFATc1, suggesting that this effect was mediated by a noncanonical pathway. Wnt3a rapidly activated the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathway and pharmacological stimulation of cAMP/PKA signaling suppressed osteoclast differentiation; Wnt3a-induced NFATc1 phosphorylation was blocked by inhibiting interactions between PKA and A-kinase anchoring proteins (AKAPs). These data indicate that Wnt3a directly suppresses osteoclast differentiation through both canonical (β-catenin) and noncanonical (cAMP/PKA) pathways in osteoclast precursors. In vivo reduction of Lrp5 and Lrp6 expressions in the early osteoclast lineage via Rank promoter Cre recombination reduced trabecular bone mass, whereas disruption of Lrp5/6 expression in late osteoclast precursors via cathepsin K (Ctsk) promoter Cre recombination did not alter the skeletal phenotype. Surprisingly, reduction of Lrp5/6 in the early osteoclast lineage decreased osteoclast numbers, as well as osteoblast numbers. Published studies have previously noted that β-catenin signaling is required for osteoclast progenitor proliferation. Our in vivo data suggest that Rank promoter Cre-mediated deletion of Lrp5/6 may similarly impair osteoclast progenitor proliferation. © 2015 American Society for Bone and Mineral Research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbmr.2599

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 57

  1. Monroe, 2012, Update on Wnt signaling in bone cell biology and bone disease, Gene, 492, 1, 10.1016/j.gene.2011.10.044 · DOI · Paper page
  2. Niehrs, 2010, Regulation of Lrp6 phosphorylation, Cell Mol Life Sci, 67, 2551, 10.1007/s00018-010-0329-3 · DOI · Paper page
  3. MacDonald, 2009, Wnt/beta-catenin signaling: components, mechanisms, and diseases, Dev Cell, 17, 9, 10.1016/j.devcel.2009.06.016 · DOI · Paper page
  4. Bilic, 2007, Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation, Science, 316, 1619, 10.1126/science.1137065 · DOI · Paper page
  5. Zheng, 2005, Conservation and diversification of Wnt signaling function during the evolution of nematode vulva development, Nat Genet, 37, 300, 10.1038/ng1512 · doi:10.1038/ng1512
  6. Fujita, 2007, Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF, Mol Cancer, 6, 71, 10.1186/1476-4598-6-71 · DOI · Paper page
  7. Wei, 2011, Biphasic and dosage-dependent regulation of osteoclastogenesis by beta-catenin, Mol Cell Biol, 31, 4706, 10.1128/MCB.05980-11 · DOI · Paper page
  8. Takeshita, 2000, Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts, J Bone Miner Res, 15, 1477, 10.1359/jbmr.2000.15.8.1477 · DOI · Paper page
  9. Gingery, 2003, Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkappaB pathways to maintain osteoclast survival, J Cell Biochem, 89, 165, 10.1002/jcb.10503 · DOI · Paper page
  10. Gingery, 2008, TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival, Exp Cell Res, 314, 2725, 10.1016/j.yexcr.2008.06.006 · DOI · Paper page
  11. Brault, 2001, Inactivation of the (β)-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development, Development, 128, 1253, 10.1242/dev.128.8.1253 · DOI · Paper page
  12. Joeng, 2011, Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo, Dev Biol, 359, 222, 10.1016/j.ydbio.2011.08.020 · DOI
  13. Chiu, 2004, Transgenic mice that express Cre recombinase in osteoclasts, Genesis, 39, 178, 10.1002/gene.20041 · DOI
  14. Song, 2009, Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation, FEBS Lett, 583, 2435, 10.1016/j.febslet.2009.06.047 · DOI · Paper page
  15. Kim, 2010, Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1, J Biol Chem, 285, 5224, 10.1074/jbc.M109.042812 · DOI
  16. Koval, 2011, Yellow submarine of the Wnt/Frizzled signaling: submerging from the G protein harbor to the targets, Biochem Pharmacol, 82, 1311, 10.1016/j.bcp.2011.06.005 · DOI
  17. Wang, 2006, Structure-function analyses of Frizzleds, Cell Signal, 18, 934, 10.1016/j.cellsig.2005.12.008 · DOI · Paper page
  18. Koval, 2011, Wnt3a stimulation elicits G-protein-coupled receptor properties of mammalian Frizzled proteins, Biochem J, 433, 435, 10.1042/BJ20101878 · DOI
  19. Taylor, 2008, Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design, Biochim Biophys Acta, 1784, 16, 10.1016/j.bbapap.2007.10.002 · DOI · Paper page
  20. Skroblin, 2010, Mechanisms of protein kinase a anchoring, Int Rev Cell Mol Biol, 283, 235, 10.1016/S1937-6448(10)83005-9 · DOI · Paper page
  21. Ominsky, 2011, Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones, J Bone Miner Res, 26, 1012, 10.1002/jbmr.307 · DOI · Paper page
  22. Li, 2009, Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis, J Bone Miner Res, 24, 578, 10.1359/jbmr.081206 · DOI · Paper page
  23. Padhi, 2011, Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody, J Bone Miner Res, 26, 19, 10.1002/jbmr.173 · DOI · Paper page
  24. McColm, 2014, Single- and multiple-dose randomized studies of blosozumab, a monoclonal antibody against Sclerostin, in healthy postmenopausal women, J Bone Miner Res, 29, 935, 10.1002/jbmr.2092 · DOI · Paper page
  25. Fulciniti, 2009, Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma, Blood, 114, 371, 10.1182/blood-2008-11-191577 · DOI · Paper page
  26. Diarra, 2007, Dickkopf-1 is a master regulator of joint remodeling, Nat Med, 13, 156, 10.1038/nm1538 · DOI · Paper page
  27. Munshi, 2012, Early evidence of anabolic bone activity of BHQ880, a fully human anti-DKK1 neutralizing antibody: results of a phase 2 study in previously untreated patients with smoldering multiple myeloma at risk for progression. Paper presented at: 54th American Society of Hematology (ASH) Annual Meeting and Exposition; December 8-11, 2012; Atlanta, GA, ASH Annual Meeting Abstracts, 120, 331
  28. Modarresi, 2009, WNT/β-catenin signaling is involved in regulation of osteoclast differentiation by human immunodeficiency virus protease inhibitor ritonavir: relationship to human immunodeficiency virus-linked bone mineral loss, Am J Pathol, 174, 123, 10.2353/ajpath.2009.080484 · DOI
  29. Qiang, 2010, Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma, Br J Haematol, 148, 726, 10.1111/j.1365-2141.2009.08009.x · DOI
  30. Jang, 2011, Inactivation of glycogen synthase kinase-3β is required for osteoclast differentiation, J Biol Chem, 286, 39043, 10.1074/jbc.M111.256768 · DOI
  31. Doble, 2007, Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions, Cells Tissues Organs, 185, 73, 10.1159/000101306 · DOI · Paper page
  32. Wu, 2010, GSK3: a multifaceted kinase in Wnt signaling, Trends Biochem Sci, 35, 161, 10.1016/j.tibs.2009.10.002 · DOI · Paper page
  33. Liang, 2003, Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression, Cell Cycle, 2, 339, 10.4161/cc.2.4.433 · DOI · Paper page
  34. Yu, 1996, Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer, Br J Cancer, 74, 1242, 10.1038/bjc.1996.523 · DOI
  35. Sanchez-Fernandez, 2008, Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling, PLoS One, 3, e3537, 10.1371/journal.pone.0003537 · DOI
  36. Lotinun, 2013, Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation, J Clin Invest, 123, 666
  37. Ryu, 2006, Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling, EMBO J, 25, 5840, 10.1038/sj.emboj.7601430 · DOI · Paper page
  38. Takeshita, 2013, Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation, J Clin Invest, 123, 3914, 10.1172/JCI69493 · DOI · Paper page
  39. Quint, 2013, Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways, J Biol Chem, 288, 5398, 10.1074/jbc.M112.413583 · DOI
  40. Kiechl, 2013, Blockade of receptor activator of nuclear factor-[kappa]B (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus, Nat Med, 19, 358, 10.1038/nm.3084 · DOI · Paper page
  41. Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function, Nature, 390, 175, 10.1038/36593 · DOI · Paper page
  42. Angers, 2009, Proximal events in Wnt signal transduction, Nat Rev Mol Cell Biol, 10, 468, 10.1038/nrm2717 · DOI · Paper page
  43. Santiago, 2012, Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir, Biochem Biophys Res Commun, 417, 223, 10.1016/j.bbrc.2011.11.089 · DOI
  44. Witze, 2008, Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors, Science, 320, 365, 10.1126/science.1151250 · DOI · Paper page
  45. Sheridan, 2002, Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3, J Biol Chem, 277, 48664, 10.1074/jbc.M207029200 · DOI
  46. Yoon, 2011, Adenylate cyclase and calmodulin-dependent kinase have opposite effects on osteoclastogenesis by regulating the PKA-NFATc1 pathway, J Bone Miner Res, 26, 1217, 10.1002/jbmr.310 · DOI
  47. Tanji, 2002, A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3β (GSK-3β) and mediates protein kinase A-dependent inhibition of GSK-3β, J Biol Chem, 277, 36955, 10.1074/jbc.M206210200 · DOI
  48. Zardawi, 2009, Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer, Histol Histopathol, 24, 385
  49. Ayyanan, 2006, Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism, Proc Natl Acad Sci USA, 103, 3799, 10.1073/pnas.0600065103 · DOI · Paper page
  50. Olson, 1994, Regulated expression of Wnt family members during proliferation of C57mg mammary cells, Cell Growth Differ, 5, 197
  51. Wong, 1994, Differential transformation of mammary epithelial cells by Wnt genes, Mol Cell Biol, 14, 6278
  52. Benhaj, 2006, Redundant expression of canonical Wnt ligands in human breast cancer cell lines, Oncol Rep, 15, 701
  53. Bankfalvi, 1999, Immunophenotypic and prognostic analyses of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44, Histopathology, 34, 25, 10.1046/j.1365-2559.1999.00540.x · doi:10.1046/j.1365-2559.1999.00540.x
  54. Karayiannakis, 2001, Expression patterns of beta-catenin in in situ and invasive breast cancer, Eur J Surg Oncol, 27, 31, 10.1053/ejso.1999.1017 · doi:10.1053/ejso.1999.1017
  55. Wong, 2002, Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours, J Pathol, 196, 145, 10.1002/path.1035 · DOI
  56. Li, 2000, Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer, Oncogene, 19, 1002, 10.1038/sj.onc.1203273 · DOI · Paper page
  57. Jonsson, 2000, Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer, Eur J Cancer, 36, 242, 10.1016/S0959-8049(99)00276-2 · DOI

Cited by

See all 159

Metadata

Authors
Weivoda, M. M., Ruan, M., Hachfeld, C. M., Pederson, L., Howe, A., Davey, R. A., Zajac, J. D., Kobayashi, Y., Williams, B. O., Westendorf, J. J., Khosla, S., & Oursler, M. J.
Venue
Journal of Bone and Mineral Research
Published
2015-07-18
Volume
31
Issue
1
Pages
65-75
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W1927572613
Cited by
159
References
4
FWCI
5.02
Type
journal article
Language
en
Update notices
erratum (2019-05-22)
Open access
green
Funders
National Institutes of Health (F32 AR064679, T32 AR056950, R01 AR053293, P01 AG004875P3, P01 AG004875P4, R01 GM097495, R01 DE020194)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways. https://app.cochat.ai/papers/10.1002/jbmr.2599
The paper
Weivoda, M. M., Ruan, M., Hachfeld, C. M., Pederson, L., Howe, A., Davey, R. A., Zajac, J. D., Kobayashi, Y., Williams, B. O., Westendorf, J. J., Khosla, S., & Oursler, M. J. (2016). Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.2599

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.